Dear Gov. Brown, What's a Vagina Worth? I Support Women's Rights

(800) 511-3838 |

What They Knew

According to ConsumerSafety.org, “The connection [between talc and ovarian cancer] was first suggested in 1971, when a group of gynecologic oncologists noticed that 75% of the tumors they investigated contained talc particles. Since then, many researchers have agreed that talc use increases the risk of developing cancer. Recently, a report from May 2016 determined that 63% of women with ovarian cancer had dusted themselves with talcum powder.”

There are two distinct theories as to how talcum powder causes ovarian cancer. The first explains that when talcum powder is applied to the genitals, it can travel up the fallopian tubes and into the ovaries. This may irritate the tissue causing cells to irregularly multiple resulting in cancer. A second (and more recent) conclusion is that some talcum powder is contaminated with asbestos, a well-known carcinogen. Talc and asbestos are closely related: both are silicate minerals and both talc and amphibole asbestos – known as tremolite – are created by the same geologic processes and are both are forms of magnesium silicate. Many talc mines were contaminated with these tremolite asbestos fibers and then were made into talc products. Talc products have been tested for asbestos since the 1970’s, but according to two recent trials held in March and May 2018, the asbestos found in current talcum powder resulted in two patients being diagnosed with cancer (one in 2016).

When They Knew

Johnson & Johnson has known since 1971 that their baby powder could cause cancer, and yet they continue to deny these claims. The least that this billion dollar company can do is put a warning label on their product, and yet they refuse to do so because they believe that it will confuse their buyers. However, Valeant Pharmaceuticals, which bought J&J’s Shower to Shower brand, has a label on their talcum powder that currently states that is it, “intended for external use only” and that, “frequent application of talcum powder in the female genital area may increase the risk of ovarian cancer.”

What Can You Do?

If you or a loved one was diagnosed with ovarian cancer, you may be able to join the more than 6,000 other women who have filed claims against Johnson & Johnson. You may qualify if you:

  • Were diagnosed with ovarian cancer after 2006
  • Applied J&J’s baby powder to your genitals once a week for four years or once a day for two years or more.
  • Had major surgery, chemotherapy or radiation therapy after 2006
  • Had a loved one who died after 2006 due to ovarian cancer

You were never warned of the risk of using baby powder and Johnson & Johnson put sales above warning their faithful consumers. Contact us today. We would love to hear your story.

Talcum Powder Warnings In The News

BREAKING (7/13/18): J&J’s Talcum Powder is Blamed for Ovarian Cancer, Victims Awarded over $4 Billion

Yesterday in St. Louis, a jury decided that Johnson & Johnson’s talcum powder is to blame for causing ovarian cancer in the 22 plaintiffs represented. The jury awarded $550 million in actual damages and $4 billion in punitive damages which means that each family who sued will potentially receive approximately $25 million.

While there have been previous trials in which women have claimed that talcum powder causes ovarian cancer, what makes this one different is the argument that their cancer was caused by the asbestos allegedly found in this product. Furthermore, this is the first trial where documentation was presented revealing that the leadership of J&J knew that there was asbestos found in their product and yet failed to warn consumers.

Read Full Article

5/25/18: J&J Jury Asks Judge to Slap Cancer Warning on Baby Powder

If Johnson & Johnson won’t put a warning on its baby powder that it may be tainted with asbestos, some jurors were ready to do it for them.

A California jury weighing J&J’s punishment over its handling of its iconic baby powder asked a judge May 24 if they could force the company to warn consumers that its Johnson’s Baby Powder could be contaminated with asbestos, according to the law firm that won the case against the health-care giant.

Read Full Article

5/23/18: J&j Hit With $21.7 Million Verdict in Another Talc Asbestos Cancer Case

Johnson & Johnson (JNJ.N) and its talc suppliers on Wednesday were hit with a $21.7 million jury verdict in a lawsuit by a woman who said she developed cancer after being exposed to asbestos in the company’s Baby Powder.

The verdict by a Los Angeles jury came down in the case of 68-year-old Joanne Anderson, who was diagnosed with mesothelioma, a form of cancer closely linked to asbestos exposure, and marked the second trial loss for J&J over similar allegations.

Of the $21.7 million the jury awarded in compensatory damages, J&J was assigned 67 percent, with the rest distributed among other defendants.

Read Full Article

 

5/21/18: Johnson & Johnson Continues to Battle in Court Over Cancer Causing Baby Powder

For decades Johnson & Johnson, the makers of the iconic baby powder, have denied claims that their product contains traces of potentially carcinogenic (cancer causing) asbestos. However, recent trials have determined that J&J’s baby powder is to blame for two victims who were diagnosed with mesothelioma. Current, a third trial is taking place in St. Louis involving 22 women who have been diagnosed with ovarian cancer after using this product. The evidence presented in these trials could impact the outcome of future cases concerning J&J and the link between talcum powder, asbestos, and cancer.

Read Full Article

4/11/18: Does Talcum Powder Cause Cancer? A Legal and Scientific Battle Rages

Visitors who walk into Deborah Giannecchini’s ranch house in Modesto, California, will notice a well-tended garden, four small dogs who greet every visitor with enthusiasm and a sign that hangs prominently displayed in her living room that reads “It’s never too late to live happily ever after.”

She got it when she was 62 years old, after she married her husband, Leland, but it could also represent her current mission: to help other women avoid the pain she’s experienced and allow them to have their own happy endings.

Read Full Article

GET YOUR FREE Talcum Powder CASE REVIEW TODAY

Talcum Powder settlements are now being negotiated, but there is a limited window to pursue help. If you think you, a friend, or a family member may qualify, get your free case review today… before it’s too late!

  • * Submit now to learn if you may be eligible for a cash settlement or call (800) 511-3838 now.

Our in-house legal counsel, Matthew J. Daher, earned his Bachelor of Arts degree from the University of Utah and his law degree from the University of Missouri – Columbia School of Law. Matt has devoted his entire practice to civil litigation, and has spent his career representing the rights of individuals who have been injured by pharmaceuticals, medical devices, medical malpractice, defective products, and motor vehicle accidents. As in-house counsel for Periscope Group, Matt leads our internal legal team and liaises with our external partners.

Free Guide Download

The Step-By-Step Guide To Taking Action

How to File for Financial Settlement After Injury from an Unsafe Drug or Device

Free Guide Download

The Step-By-Step Guide To Taking Action

How to File for Financial Settlement After Injury from an Unsafe Drug or Device

LATEST ARTICLES

How Could I Get Cancer from My Blood Pressure Medication?

On January 3, 2019, the Food and Drug Administration (FDA) posted an updated notice to consumers explaining that Torrent Pharmaceuticals was expanding its recall to eight (8) additional lots of its high blood pressure medication Losartan. This recall is a continuation of what started over the past summer on July 27, 2018. The FDA initially warned that certain batches of the high blood pressure drug Valsartan had been contaminated with the chemical N-nitrosodimethylamine (NDMA). To date, there have been numerous recalls issued to multiple manufacturers of these specific high blood pressure drugs.

To date, there have been numerous recalls of popular high-blood-pressure drugs—sourced internationally from dubious manufacturers. How can you really trust the source of your drugs?

The FDA’s recall this past July came after 22 other countries issued recalls involving 2,300 valsartan batches sent to Germany, Norway, Finland, Sweden, Hungary, the Netherlands, Austria, Ireland, Bulgaria, Italy, Spain, Portugal, Belgium, France, Poland, Croatia, Lithuania, Greece, Canada, Bosnia and Herzegovina, Bahrain and Malta.

Based on additional findings by the FDA, the NDMA contained in these recalled products was manufactured by a company in China called Zhejiang Huahai Pharmaceuticals.

NDMA is known to cause cancer as well as liver damage. The FDA believes “the NDMA is related to changes in the way the active substance was manufactured” and that “some levels of impurity may have been in the valsartan containing products for as long as four years.”  

The recall itself is frightening. The folks taking these medications are already dealing with cardiovascular issues and high-blood pressure. Plus, how many people in this country understood at the time they were given their prescriptions that the drugs they were ingesting were being manufactured or had traveled all over the world from places like Israel, India, or even China.

Let’s say, for example, you live in a small rural community in the Midwest. Like so many other people in this country, you suffer from high-blood pressure. You’ve tried changing your diet, you’ve been exercising regularly, and you’ve tried anti-anxiety therapies as well. After exhausting numerous options to bring down your blood pressure, your doctor finally tells you it’s time to get on some medication. So, that’s what you do. Over the next year or two, you get your blood pressure under control and feel like your life is back to normal. Then the FDA issues the recall this past July and you find out that the medication you’ve been taking to manage your blood pressure was contaminated with a potentially cancer-causing ingredient. Also, it came from China.  

This Valsartan and Losartan recall speak to a bigger issue we all currently face when we take a prescription drug or have a medical device implant. Where exactly are all of these prescription drugs or medical devices being manufactured or sent before we ingest them or have them implanted in our bodies?

A pharmaceutical consulting group called Evaluate recently issued a report this past June predicting where global pharmaceutical sales would be by 2024. After conducting exhaustive research with the world’s leading 7,000 pharmaceutical and biotech companies, the report concluded that, globally,total prescription sales are expected to be $1.2trn in 2024.

Similarly, this past April, a research consulting group called Lucintel conducted a similar study to the global medical device market. The results from that study predicted enormous amounts of future sales across the world: “the global medical device market is expected to reach an estimated $409.5 billion by 2023.”

Yes, it may be our local doctor in our local community who is giving the prescription. Yes, it may be a local surgeon who performed our medical device implant surgery. We may know the doctor, but what do we know about the pill(s) they prescribe us or the medical device(s) they implant us with? Even scarier, given the fact that so many prescriptions were issued for these contaminated high-blood pressure medications, how much information do your healthcare providers have as well?  

 

Image Source

Essure has Been Removed From the Market. What is the FDA Doing to Monitor Patients?

As of December 31, 2018, Bayer voluntarily removed its Essure birth control medical device from the market due to lagging sales and the controversies surrounding it’s safety. However, just because it’s no longer an active product on the market doesn’t mean the the FDA is putting this issue to rest. There are several ways that the FDA intends to stay informed concerning patient health and monitor postmarket safety. If you have an Essure implant, here’s some important information to be aware of.

Essure has Been Removed From the Market. What is the FDA Doing to Monitor Patients?

Why Did Bayer Take Essure Off the Market?

Essure was fast-tracked through the FDA in 2002 and by 2015 had over 15,000 adverse reports filed in the U.S. alone. This paperwork involved patients and doctors reporting medical complaints and complications. These problems included allergic reactions to nickel which led to autoimmune disorders, the coil-like device breaking apart and moving to other parts of the body where they punctured and sliced organs, and possibly even being linked to patient and fetus deaths. In 2016, the FDA required that Bayer – the makers of Essure – conduct a mandatory clinical study on the product, add a warning to the label, AND create a patient checklist listing all of the risks that have been associated with this specific birth control device. Over a million devices were sold worldwide before 2015. After this new protocol, sales dropped by 70 percent in the U.S. Bayer said in a public statement, “Our decision to discontinue sales is for business reasons, and not for any safety or efficacy concerns about Essure.

Will the FDA Monitor This Off-Market Implant?

Yes. While the FDA may have approved Essure too quickly for market, they are at least trying to monitor some of the complications left in the wake of this dangerous medical device. Remember that mandatory study that the FDA required of Bayer back in 2016? The FDA is ensuring that Bayer finishes this study with a few new guidelines:

  • Instead of monitoring the patients in the study for just three years, the time period has increased to five years. “This extension will provide us with longer-term information on adverse risks of the device, including issues that may lead women to have the device removed,” explained FDA Commissioner Dr. Scott Gottlieb.
  • One common complaint involving these patients included symptoms associated with inflammation and autoimmune diseases. This could very well be allergic reactions to the nickel that is found in these medical devices. Studies have shown that approximately 15% of women are allergic to nickel. (When you consider that around 1 million women had an Essure implant, that’s 150,000 who are struggling from just this one complication. Also, consider that testing wasn’t done to see if these patients were allergic to nickel BEFORE they were implanted with it!)

The FDA is requiring additional blood tests for the women in the study to track inflammation against inflammatory markers to analyze their symptoms with allergic reactions.

  • “The FDA is also requiring Bayer to continue to enroll patients who might still opt to receive Essure in advance of its full discontinuation from the U.S. market, and to continue to submit more frequent reports to the FDA on the study’s progress and results,” Gottlieb said.
  • The FDA has stated that they will continue to monitor the performance of Essure in women and will make interim study results and updates available on their Essure Postmarket Surveillance Study page.

What Should You Do If You Have an Essure Implant?

If you have an Essure implant and aren’t experiencing intense lower back or pelvic pain, fatigue, brain fog, painful intercourse, heavy periods, and other symptoms, then the FDA advises that you leave your implant in place. Listen to your body and educate yourself on the signs to be aware of if something should unfortunately go wrong. However, if you are experiencing these symptoms, talk to your doctor right way. He or she may discuss various options with you so that you can take back control of your health.

 

##
Sources
“UPDATE: FDA updates on post-market study revisions, oversight for Bayer’s Essure”. Mass Device. Accessed January 17, 2019. https://www.massdevice.com/fda-updates-on-post-market-study-revisions-oversight-for-bayers-essure/?spMailingID=14841927&spUserID=Mjk4ODUzMDA1MTY5S0&spJobID=1541789487&spReportId=MTU0MTc4OTQ4NwS2
“FDA Activities: Essure”. FDA. Accessed January 17, 2019. https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/EssurePermanentBirthControl/ucm452254.htm
“F.D.A. Panel Weighs Complaints on Essure Contraceptive Implant”. The New York Times. Accessed January 17, 2019. https://www.nytimes.com/2015/09/25/health/fda-panel-discusses-essure-contraceptive-implant.html
“Bayer To Take Birth Control Device Essure Off the U.S. Market”. Managed Care. Accessed January 17, 2019. https://www.managedcaremag.com/news/20180724/bayer-take-birth-control-device-essure-us-market

“FDA Announces Safety Monitoring for Essure”. WebMD.  Accessed January 17, 2019. https://www.webmd.com/sex/birth-control/news/20181224/fda-announces-safety-monitoring-for-essure

Periscope Group is not owned by or operated on behalf of any attorney or law firm. We are not affiliated with any drug or medical device companies. We do not host advertisements nor do we accept advertising requests. We are here to help YOU, the consumer, become better educated and supported. You pay absolutely nothing for our help. It’s as simple as that.

Periscope Group is not owned by or operated on behalf of any attorney or law firm. We are not affiliated with any drug or medical device companies. We do not host advertisements nor do we accept advertising requests. We are here to help YOU, the consumer, become better educated and supported. You pay absolutely nothing for our help. It’s as simple as that.

HON Code Certification

© All Rights Reserved • 2017 • Periscope Group, 4155 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506 Legal Disclaimer

Protected by Copyscape

© All Rights Reserved • 2017 • Periscope Group, 4155 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506 Legal Disclaimer

HON Code Certification

Pin It on Pinterest